Vir Biotechnology, Inc. VIR Other Non-Current Assets
Other Non-Current Assets at other companies
Other financials
Where this comes from
Reported directly by Vir Biotechnology, Inc. in its filing.
Tagged under the XBRL concept us-gaap:OtherAssets.
The official record: Vir Biotechnology, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Vir Biotechnology, Inc.'s other non-current assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Vir Biotechnology, Inc.'s other non-current assets?
- Vir Biotechnology, Inc. (VIR) reported other non-current assets of $24.04M in Q1 2026.
- How has Vir Biotechnology, Inc.'s other non-current assets changed year-over-year?
- Vir Biotechnology, Inc.'s other non-current assets increased by 310.4% year-over-year, from $5.86M to $24.04M.
- What is the long-term trend for Vir Biotechnology, Inc.'s other non-current assets?
- Over 5 years (2020 to 2025), Vir Biotechnology, Inc.'s other non-current assets has grown at a 22.8% compound annual growth rate (CAGR), from $8.83M to $24.7M.
- What does other non-current assets mean?
- Long-term assets not classified in specific categories — a catch-all for miscellaneous non-current assets.